Expansion opportunities Amber is a Hy-Vee subsidiary with national reach, serving all 50 states and Puerto Rico. This presents cross-sell potential with Hy-Vee’s existing customers and leverage for payer and provider network expansions across diverse markets.

High‑value collaborations Recent partnership with Vivid Clear Rx indicates openness to strategic alliances for complex therapies. Explore additional partnerships with specialty drug manufacturers, PBMs, and tech-enabled pharmacy services to broaden the patient access network.

Transplant and rare disease focus Strength in organ transplant and rare/orphan conditions suggests upsell opportunities with clinics, transplant centers, and disease management programs seeking integrated patient support, adherence programs, and rapid dispensing capabilities.

Recognition and credibility NASP Specialty Pharmacy of the Year awards bolster credibility with potential customers and referral sources. Leverage awards in outreach to gain introductions to hospitals, life sciences firms, and sponsor-driven patient care initiatives.

Leadership and innovation New president appointment and SVP of business innovation indicate a growth-focused leadership trajectory. Target growth-stage drug launches, specialty therapies, and payer programs that require agile operations and innovative patient management.